aid: beam-therapeutics accessModel: pricing: unknown onboarding: unknown trial: false try_now: false public: false label: Unknown confidence: low source: [] generated: '2026-07-22' method: derived image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/beam-therapeutics.png name: Beam Therapeutics * description: 'Beam Therapeutics is a biotechnology company pioneering precision genetic medicines through base editing, a technology that makes precise, predictable, and efficient single-base changes to the genome without cutting the DNA double helix. The company is developing a portfolio of investigational base editing programs across hematology, hepatology, and other therapeutic areas, using multiple delivery modalities including electroporation, nonviral lipid nanoparticles, and viral vectors. Publicly traded on Nasdaq as BEAM, Beam was named a TIME100 Most Influential Company in 2026. This profile was surfaced as a portfolio company of gv and hongshan; it is a life-sciences company with no public developer/API surface at this time.' url: https://raw.githubusercontent.com/api-evangelist/beam-therapeutics/refs/heads/main/apis.yml x-type: company x-source: vc-portfolio x-backed-by: - gv - hongshan x-tier: stub x-tier-reason: portfolio-lead specificationVersion: '0.20' created: '2026-07-17' modified: '2026-07-18' tags: - Company - Life Sciences - Biotechnology - Genetic Medicine - Base Editing - Gene Editing - Therapeutics - Precision Medicine apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: DomainSecurity url: security/beam-therapeutics-domain-security.yml - type: Website url: https://beamtx.com - type: Support url: https://beamtx.com/contact/ - type: PrivacyPolicy url: https://beamtx.com/privacy-policy/ - type: TermsOfService url: https://beamtx.com/terms-of-use/ x-enrichment: date: '2026-07-19' status: backfilled pass: local-v1 note: backfilled from .gitignore signal + verified work evidence